SCHEMBL14101572

SCHEMBL14101572

c1ccc(-c2ccc3ccc4c(-c5ccc6c(c5)sc5cc(-c7ccc8ccc9c(-c%10ccccc%10)ccc%10ccc7c8c%109)ccc56)ccc5ccc2c3c54)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F9 P00740 3/20 0.38
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LIMK1 P53667 3/20 0.35
PIK3CA P42336 1/20 0.35
PI4KA P42356 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
SLC9A1 P19634 1/20 0.34
ERBB2 P04626 1/20 0.33
CYP1A2 P05177 1/20 0.33
FYN P06241 1/20 0.33
MAOA P21397 1/20 0.33
ACHE P22303 1/20 0.33
AHR P35869 1/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
GPR3 P46089 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101571 0.98 LIMK1 (0.38) F9ALDH1A1MAPTHPGDRAB9A
SCHEMBL14101627 0.97 LIMK1 (0.40) F9ALDH1A1MAPTHPGDRAB9A
SCHEMBL14101628 0.97 LIMK1 (0.40) F9ALDH1A1MAPTHPGDRAB9A
SCHEMBL14101573 0.95 CYP1A2 (0.41) F9ALDH1A1MAPTHPGDRAB9A
SCHEMBL14101597 0.95 F9 (0.38) F9ALDH1A1MAPTHPGDRAB9A
SCHEMBL14101585 0.95 PIK3CA (0.41) F9ALDH1A1MAPTHPGDRAB9A
SCHEMBL14101638 0.95 PIK3CA (0.41) F9ALDH1A1MAPTHPGDRAB9A
SCHEMBL14101645 0.94 LIMK1 (0.38) F9LIMK1PIK3CAPI4KAPI4KB
SCHEMBL14101574 0.94 LIMK1 (0.38) F9LIMK1PIK3CAPI4KAPI4KB
SCHEMBL14101575 0.94 F9 (0.38) F9ALDH1A1MAPTHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR F9 3290/4885ALDH1A1 70/4885MAPT 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.